KFI is delighted to announce that construction on the new canine and feline housing, enrichment and procedural space has been completed and has passed the OMAFRA licensing inspection required for research facilities in Ontario to operate. The 5,000 sq foot expansion...
Solensia® is the first feline injectable mAB designed specifically for cats suffering from pain associated with osteoarthritis. The European Commission granted Zoetis Inc. the marketing authorization on Feb. 22, 2021. This once monthly feline injectable targets and...
FDA’s Center for Veterinary Medicine approved Elanco US Inc.’s NADA for ELURA™ on Oct. 16th, 2020. Elura™ is an oral solution of capromorelin developed for the management of weight loss in cats with chronic kidney disease (CKD). This is the first drug specifically...
Construction on new state-of-the art canine and feline housing, enrichment, and procedure space will begin this fall. “Our focus remains to deliver high quality and compassionate science to help change and improve the lives of companion animals” said Dr. Niemuller....
FDA’s Center for Veterinary Medicine approved Felix Pharmaceuticals Pvt. Ltd.’s ANADA for Enrofloxacin Flavored Tablets on May 21, 2020. The flavored tablets provide veterinarians with a new treatment option for disease associated with bacteria susceptible to...
Recent Comments